Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19
Thomas Hueso, Cécile Pouderoux, Hélène Péré, et al.
Blood (2020) Vol. 136, Iss. 20, pp. 2290-2295
Open Access | Times Cited: 283

Showing 1-25 of 283 citing articles:

Viral targets for vaccines against COVID-19
Lianpan Dai, George F. Gao
Nature reviews. Immunology (2020) Vol. 21, Iss. 2, pp. 73-82
Open Access | Times Cited: 1060
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
Yair Herishanu, Irit Avivi, Anat Aharon, et al.
Blood (2021) Vol. 137, Iss. 23, pp. 3165-3173
Open Access | Times Cited: 603
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
Michael A. Thompson, Jeffrey P. Henderson, Pankil Shah, et al.
JAMA Oncology (2021) Vol. 7, Iss. 8, pp. 1167-1167
Open Access | Times Cited: 174
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
David M. Smadja, Steven J. Mentzer, Michaëla Fontenay, et al.
Angiogenesis (2021) Vol. 24, Iss. 4, pp. 755-788
Open Access | Times Cited: 164
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma
Chava Perry, Efrat Luttwak, R. Balaban, et al.
Blood Advances (2021) Vol. 5, Iss. 16, pp. 3053-3061
Open Access | Times Cited: 159
Immunity to SARS‐CoV‐2 induced by infection or vaccination
Xaquín Castro Dopico, Sebastian Ols, Karin Loré, et al.
Journal of Internal Medicine (2021) Vol. 291, Iss. 1, pp. 32-50
Open Access | Times Cited: 151
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis
Stephen A. Klassen, Jonathon W. Senefeld, Patrick W. Johnson, et al.
Mayo Clinic Proceedings (2021) Vol. 96, Iss. 5, pp. 1262-1275
Open Access | Times Cited: 150
The humoral response and antibodies against SARS-CoV-2 infection
Hai Qi, Bo Liu, Xinquan Wang, et al.
Nature Immunology (2022) Vol. 23, Iss. 7, pp. 1008-1020
Open Access | Times Cited: 147
Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with non‐Hodgkin lymphoma treated with B‐cell depleting immunotherapy
Rémy Duléry, Sylvain Lamure, Marc Delord, et al.
American Journal of Hematology (2021) Vol. 96, Iss. 8, pp. 934-944
Open Access | Times Cited: 136
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2250647-e2250647
Open Access | Times Cited: 129
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
Florent Malard, Béatrice Gaugler, Joël Gozlan, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 8
Open Access | Times Cited: 126
COVID-19 in patients with hematologic malignancy
Petra Langerbeins, Michael Hallek
Blood (2022) Vol. 140, Iss. 3, pp. 236-252
Open Access | Times Cited: 110
SARS-CoV-2 in immunocompromised individuals
Susan DeWolf, Justin Laracy, Miguel-Ángel Perales, et al.
Immunity (2022) Vol. 55, Iss. 10, pp. 1779-1798
Open Access | Times Cited: 89
SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19
Oksana V. Stanevich, Evgeniia Alekseeva, Maria V. Sergeeva, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 47
Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019
M. Martinot, Aude Jary, Samira Fafi‐Kremer, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 7, pp. e1762-e1765
Open Access | Times Cited: 111
Evidence favouring the efficacy of convalescent plasma for COVID-19 therapy
Michael J. Joyner, Stephen A. Klassen, Jonathon W. Senefeld, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 89
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient—A Case Study
Chiara Sepulcri, Chiara Dentone, Małgorzata Mikulska, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 11
Open Access | Times Cited: 85
Use of convalescent plasma inCOVID‐19 patients with immunosuppression
Jonathon W. Senefeld, Stephen A. Klassen, Shane Ford, et al.
Transfusion (2021) Vol. 61, Iss. 8, pp. 2503-2511
Open Access | Times Cited: 76
Treatment of chronic or relapsing COVID-19 in immunodeficiency
Li‐An K. Brown, Ed Moran, Anna L. Goodman, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 2, pp. 557-561.e1
Open Access | Times Cited: 73
COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review
Jessica Jones, Aiman Faruqi, James Sullivan, et al.
Pathogens and Immunity (2021) Vol. 6, Iss. 1, pp. 76-103
Open Access | Times Cited: 72
Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma
Irit Avivi, Roi Balaban, Tamir Shragai, et al.
British Journal of Haematology (2021) Vol. 195, Iss. 2, pp. 186-193
Open Access | Times Cited: 71
Incidence, Clinical Presentation, Relapses and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Patients Treated With Anti-CD20 Monoclonal Antibodies
Jorge Calderón‐Parra, Elena Múñez, Ana Fernández‐Cruz, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 10, pp. 1786-1794
Open Access | Times Cited: 65
Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis
Son Tran, Tony H. Truong, Aru Narendran
European Journal of Cancer (2021) Vol. 159, pp. 259-274
Open Access | Times Cited: 65
Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses
Stephan Schlickeiser, Tatjana Schwarz, Sophie Steiner, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 64
A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice
Tianyang Mao, Benjamin Israelow, Carolina Lucas, et al.
The Journal of Experimental Medicine (2021) Vol. 219, Iss. 1
Open Access | Times Cited: 62
Page 1 - Next Page

Scroll to top